GH termed illegal for off-label usage Off-label distribution or provision of growth hormone for treating aging and other forms of age-associated illness is illegal in the United States as per a report in the Journal of the American Medical Association.

The authors of this study were Dr. Thomas Perls, Director of the New England Centenarian Study at Boston Medical Center and associate professor of medicine at Boston University School of Medicine; Dr. Neal Reisman, clinical professor of plastic surgery at Baylor College of Medicine and associate chief of plastic surgery at St. Luke’s Episcopal Hospital, who is also an attorney; and S. Jay Olshansky, professor of epidemiology at the University of Illinois at Chicago School of Public Health.

It was remarked by Reisman that this study paper can prove its worth by creating enough awareness about legal issues surrounding improper distribution, marketing, and discouraging criminal practices in respect to growth hormone.

Comments

comments